Fig. 1From: Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)Modified with permission from Sormani et al. defining and scoring response to IFN‑β in multiple sclerosis. Nat. Rev. Neurol. doi:10.1038/nrneurol.2013.146 Back to article page